Every Form 4 that Helus Pharma Inc. (HELP) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow HELP and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HELP filings page.
Cybin Inc. director Eric H. L. So received a grant of 248,000 restricted stock units on September 30, 2026, with immediate vesting. Each RSU represents a right to receive one common share. He reported 4,713,014 common shares held directly following the grant. The report also lists 53,616 common shares held by his spouse as of September 30, 2026.
Cybin Inc. (HELP) Chief Financial Officer Greg Cavers reported an indirect purchase of 3,000 common shares held by his spouse on September 29, 2026, at C$18.3157 per share (US$12.9100 using an exchange rate of C$1.4188 = US$1.00). No Rule 10b5-1 plan is reported. Cavers reported 125,937 common shares held directly following the transaction.
CYBIN INC. (HELP) Chief Growth Officer Paul Glavine received a grant of 248,000 restricted stock units on September 30, 2026. The units vested immediately, and each represents a right to receive one common share. His reported direct holdings after the grant were 4,750,191 shares. Those holdings include shares transferred from the PLG Family Trust that were previously reported as indirect holdings; the footnote gives that amount as 230,941 shares, reduced to 230,939 due to rounding.
CYBIN INC. (HELP) reported that Chief Executive Officer Michael Halstead purchased 100,000 Common Shares on September 21, 2026. The weighted average purchase price was $13.4705 per share, with individual trades executed between $13.395 and $13.53. After these open-market purchases, he directly owns 168,568 Common Shares.
CYBIN INC. (HELP) officer Paul Glavine, Chief Growth Officer, purchased 100,000 Common Shares on September 8, 2026 at $12.4719 per share in an open-market or private transaction. Following this purchase, he holds 4,271,252 Common Shares directly, plus 230,941 Common Shares indirectly held by the PLG Family Trust. The report is filed voluntarily and states he is not subject to Section 16 reporting requirements.
CYBIN INC. (HELP) reported that Chief Growth Officer Paul Glavine voluntarily filed an ownership report showing he purchased 100,000 Common Shares on September 8, 2026 in an open-market or private transaction at $12.4719 per share. After this purchase, he holds 4,271,252 Common Shares directly and 230,941 Common Shares indirectly through the PLG Family Trust. The filing notes he is not otherwise subject to Section 16 reporting requirements and that no Rule 10b5-1 trading plan is reported.
CYBIN INC. (HELP) reported that Executive Chair Eric H. L. So voluntarily filed a Form 4 disclosing an open-market or private purchase of 100,000 Common Shares on September 8, 2026 at $12.3867 per share. Following this purchase, he holds 4,465,014 Common Shares directly and 53,616 Common Shares indirectly through his spouse. No Rule 10b5-1 plan is reported.
CYBIN INC. (HELP) Executive Chair Eric H. L. So voluntarily reported buying 100,000 Common Shares on September 4, 2026 in an open-market or private purchase at 12.089 per share. Following this purchase, he holds 4,365,014 Common Shares directly and an additional 53,616 shares indirectly, held by his spouse. No Rule 10b5-1 trading plan is reported.
CYBIN INC. (symbol HELP) reports that Chief Growth Officer Paul Glavine purchased 100,000 Common Shares on September 3, 2026 in an open-market or private transaction at an average price of $11.7828 per share. After this trade, he holds 4,171,252 Common Shares directly and 230,941 Common Shares indirectly through the PLG Family Trust. This Form 4 was filed voluntarily, and no Rule 10b5-1 trading plan is reported.
CYBIN INC. (HELP) reports that Executive Chair Eric H. L. So voluntarily filed a Form 4 disclosing an open-market purchase of 95,000 Common Shares on September 1, 2026 at $11.805 per share. Following this transaction, he holds 4,265,014 Common Shares directly and 53,616 Common Shares indirectly through his spouse. No Rule 10b5-1 trading plan is reported, and the filing notes he is not otherwise subject to Section 16 reporting requirements.
CYBIN INC. (HELP) reports that Chief Growth Officer Paul Glavine purchased 90,000 Common Shares on August 31, 2026 at $11.5853 per share in an open-market or private transaction. After this buy, he holds 4,071,252 Common Shares directly and 230,941 shares indirectly through the PLG Family Trust. No Rule 10b5-1 trading plan is reported, and the filing is made voluntarily, as he is not subject to Section 16 reporting requirements.